242 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
or governmental agency, department or body that are currently necessary for the operation of the business of the Company and its Subsidiaries as currently … regulations and executive orders administered by the U.S. Department of the Treasury Office of Foreign Asset Control.
3.33 Cybersecurity
8-K
EX-4.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
, an unincorporated organization, any other entity and a government or any department or agency thereof.
“Principal Trading Market” means the national securities
8-K
EX-10.11
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
stockholder approval.
Participation
An Eligible Employee may participate in the Plan by (i) submitting to the Company’s Finance department (or its delegate … account and not yet used to exercise his or her option under the Plan at any time by (a) submitting to the Company’s Finance department (or its delegate
425
EX-10.1
ORKA
Oruka Therapeutics Inc.
15 Aug 24
Business combination disclosure
4:17pm
or quasi-governmental authority of any nature (including any governmental division, department, agency, commission, bureau, instrumentality, official
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
15 Aug 24
Entry into a Material Definitive Agreement
4:15pm
or quasi-governmental authority of any nature (including any governmental division, department, agency, commission, bureau, instrumentality, official
424B3
8kx4z1gf1ydimnl
1 Aug 24
Prospectus supplement
4:10pm
425
h5z 5ap9oe9ksy97w
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
2yl5jzd
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am